Carcinoma in Situ
Also known as: In Situ Carcinoma / Carcinoma in situ, unspecified / Carcinoma in situ (morphologic abnormality) / Carcinoma in situ, disorder (disorder) / Carcinoma in situ NOS / Carcinoma in situ, site unspecified
Drug | Drug Name | Drug Description |
---|
Drug | Drug Name | Target | Type |
---|
Drug | Drug Name | Phase | Status | Count |
---|---|---|---|---|
DB00855 | Aminolevulinic acid | 1 | Withdrawn | 1 |
DB14707 | Cemiplimab | 1 | Recruiting | 1 |
DB00169 | Cholecalciferol | 1 | Withdrawn | 1 |
DB13007 | Enfortumab vedotin | 1 | Recruiting | 1 |
DB00041 | Aldesleukin | 1 / 2 | Recruiting | 1 |
DB00531 | Cyclophosphamide | 1 / 2 | Recruiting | 1 |
DB01073 | Fludarabine | 1 / 2 | Recruiting | 1 |
DB00724 | Imiquimod | 2 | Completed | 1 |
DB00184 | Nicotine | 2 | Completed | 1 |
DB05148 | CG0070 | 2 / 3 | Terminated | 1 |
DB00385 | Valrubicin | 2 / 3 | Completed | 1 |
DB00305 | Mitomycin | 3 | Terminated | 1 |
DB00385 | Valrubicin | 3 | Terminated | 1 |